Emerging Markets Regulatory Tracker: Japan (Vol. 4 No. 77)
This article was originally published in PharmAsia News
Executive Summary
Japan has issued guidance on recent legal amendments relating to combination products, either drugs, devices or cellular/tissue-based therapies.